Amylyx Pharmaceuticals, Inc. (AMLX) Total assets 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) total assets at each fiscal year-end, per SEC filings.
$332.6MFY2025 · since FY2021: $105.6M → $332.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $332.6M | +71.8% |
| FY2024 | $193.6M | -62.6% |
| FY2023 | $517.5M | +32.2% |
| FY2022 | $391.5M | +270.6% |
| FY2021 | $105.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMLX financial trends
AMLX RevenueAMLX Net incomeAMLX Net marginAMLX Gross profitAMLX Gross marginAMLX Operating incomeAMLX Operating marginAMLX Operating cash flowAMLX Free cash flowAMLX Capital expendituresAMLX Return on equityAMLX Stock buybacksAMLX Dividends paidAMLX Total liabilitiesAMLX Shareholders’ equityAMLX overview →